646055-62-1 Usage
Uses
Used in Organic Synthesis:
1-Benzyl-1,7-diaza-spiro[4.4]nonane-7-carboxylic acid tert-butyl ester is used as a building block in organic synthesis for the creation of various biologically active compounds. Its Boc protection allows for selective reactions and subsequent deprotection to yield the desired products.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-Benzyl-1,7-diaza-spiro[4.4]nonane-7-carboxylic acid tert-butyl ester serves as a key component in the synthesis of pharmaceuticals. Its unique structure and Boc protection contribute to the development of new drugs with potential therapeutic applications.
Used in Peptide and Protein Synthesis:
1-Benzyl-1,7-diaza-spiro[4.4]nonane-7-carboxylic acid tert-butyl ester is used as a reagent in the preparation of peptide and protein molecules for research and pharmaceutical applications. Its Boc protection facilitates the stepwise assembly of peptides and proteins, enabling the synthesis of complex biomolecules with specific functions and properties.
Safety Precautions:
It is important to handle 1-Benzyl-1,7-diaza-spiro[4.4]nonane-7-carboxylic acid tert-butyl ester with proper safety precautions due to its potential hazards. Appropriate measures should be taken to minimize exposure and ensure the safety of researchers and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 646055-62-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,6,0,5 and 5 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 646055-62:
(8*6)+(7*4)+(6*6)+(5*0)+(4*5)+(3*5)+(2*6)+(1*2)=161
161 % 10 = 1
So 646055-62-1 is a valid CAS Registry Number.
InChI:InChI=1/C19H28N2O2/c1-18(2,3)23-17(22)20-13-11-19(15-20)10-7-12-21(19)14-16-8-5-4-6-9-16/h4-6,8-9H,7,10-15H2,1-3H3
646055-62-1Relevant articles and documents
THE USE OF N-ARYL DIAZASPIRACYCLIC COMPOUNDS IN THE TREATMENT OF ADDICTION
-
Page/Page column 57-58, (2010/10/20)
Compounds, compositions and methods for treating drug addiction, nicotine addiction, and/or obesity are disclosed. The compounds are N-aryl diazaspirocyclic compounds, bridged analogs of N-heteraryl diazaspirocyclic compounds, or prodrugs or metabolites of these compounds. The aryl group can be a five- or six-membered heterocyclic ring (heteroaryl). The compounds are effective at inhibiting dopamine production and/or secretion, and accordingly are effective at inhibiting the physiological "reward" process that is associated with ingestion of nicotine and/or illicit drugs. The compounds and compositions can be administered in effective amounts to inhibit dopamine release, wihout resulting in appreciable adverse side effects (e.g., side effects such as significant increases in blood pressure and heart rate, significant negative effects upon the gastro-intestinal tract, and significant effects upon skeletal muscle).
